Kinase Regulation by Phase Separation
The PhaseKin project aims to uncover the mechanisms of protein kinases in phase-separated condensates to enhance drug development for diseases like Alzheimer's and cancer.
Projectdetails
Introduction
Protein phosphorylation is a process that activates biological and cellular pathways. This process is carried out by enzymes called protein kinases that add phosphates to proteins. Protein kinases are crucial drug targets involved in the onset and progression of human diseases such as cancer and Alzheimer’s disease.
Regulation of Protein Kinases
Growing evidence suggests that protein kinases are regulated spatially and temporally by the phase separation and condensation of biomolecules into cellular organelles that are not surrounded by membranes. The molecular mechanisms that govern the action of kinases in phase-separated condensates, however, are unknown. Knowledge of these mechanisms is crucial for the development of better drugs that target protein kinases.
Project Overview
To address this challenge, I have designed an interdisciplinary project that goes well beyond the state-of-the-art to explore in atomic detail the action of protein kinases intimately involved in Alzheimer’s disease and the abnormal phosphorylation of the protein Tau.
Objectives of the PhaseKin Project
The PhaseKin project aims to:
- Reveal the specificity and reaction kinetics of protein kinases inside phase-separated condensates in vitro and in cells.
- Decipher the dynamic conformational landscape of the protein kinases MARK2 and GSK3β by advanced NMR methods that will grant unprecedented detail on their modes of regulation.
- Disentangle changes in population distributions and rates of interconversion between structurally distinct kinase states inside condensates.
- Unravel the physicochemical basis of kinase drug partitioning into condensates.
Innovation and Impact
The highly innovative nature of the project is devised to delve into the heart of protein kinase function and to revolutionize our knowledge about the chemistry of drug-kinase interactions. Findings from the PhaseKin project will provide critical guidance in the development of more efficacious and specific drugs which target protein kinases.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.499.943 |
Totale projectbegroting | € 2.499.943 |
Tijdlijn
Startdatum | 1-9-2024 |
Einddatum | 31-8-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EVpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Designer Condensates for Regulation of Catalytic ProcessesDevelop synthetic biomolecular condensates with tunable properties from peptide libraries to enhance reaction regulation and sustainable drug synthesis in aqueous environments. | ERC Starting... | € 1.498.750 | 2024 | Details |
Deciphering Neurodegenerative Disease with fast 3D imaging & functional nanoscopyThis project aims to investigate the biophysical mechanisms of protein aggregation in Huntington's Disease using advanced imaging techniques to enhance understanding of neurodegenerative processes. | ERC Starting... | € 1.500.000 | 2024 | Details |
Cofactors at the core of tau prion behaviourThis project aims to redefine tau prion strains by investigating how co-aggregation with cofactors influences tau aggregate structure, propagation, and associated neuropathology, enhancing drug discovery for tauopathies. | ERC Starting... | € 1.449.750 | 2022 | Details |
Engineered control of cellular circuitsDeveloping light-controlled proteins to study spatiotemporal dynamics of signaling in active neuron subpopulations during learning, aiming to inform therapies for brain disorders. | ERC Starting... | € 1.494.669 | 2023 | Details |
Interface between Membraneless Organelles and MembranesThis project aims to uncover the molecular mechanisms of interactions between liquid biomolecular condensates and membrane-bound organelles, enhancing our understanding of cellular organization and disease. | ERC Starting... | € 1.499.648 | 2024 | Details |
Designer Condensates for Regulation of Catalytic Processes
Develop synthetic biomolecular condensates with tunable properties from peptide libraries to enhance reaction regulation and sustainable drug synthesis in aqueous environments.
Deciphering Neurodegenerative Disease with fast 3D imaging & functional nanoscopy
This project aims to investigate the biophysical mechanisms of protein aggregation in Huntington's Disease using advanced imaging techniques to enhance understanding of neurodegenerative processes.
Cofactors at the core of tau prion behaviour
This project aims to redefine tau prion strains by investigating how co-aggregation with cofactors influences tau aggregate structure, propagation, and associated neuropathology, enhancing drug discovery for tauopathies.
Engineered control of cellular circuits
Developing light-controlled proteins to study spatiotemporal dynamics of signaling in active neuron subpopulations during learning, aiming to inform therapies for brain disorders.
Interface between Membraneless Organelles and Membranes
This project aims to uncover the molecular mechanisms of interactions between liquid biomolecular condensates and membrane-bound organelles, enhancing our understanding of cellular organization and disease.